PlainRecalls
FDA Devices Moderate Class II Terminated

EliA dsDNA Well - Product Usage: intended for the In-Vitro quantitative measurement of IgG antibodies directed to dsDNA in human serum and plasma as an aid in the clinical diagnosis of systemic lupus erythematosus (SLE). Material Number: 14-5500-01

Reported: February 17, 2021 Initiated: December 14, 2020 #Z-1107-2021

Product Description

EliA dsDNA Well - Product Usage: intended for the In-Vitro quantitative measurement of IgG antibodies directed to dsDNA in human serum and plasma as an aid in the clinical diagnosis of systemic lupus erythematosus (SLE). Material Number: 14-5500-01

Reason for Recall

Decreased values for EliA ANA Positive Control when using the EliA dsDNA Well lot BFA37/0142 may potentially cause false positive results (increase in patient test results).

Details

Recalling Firm
Phadia US Inc
Units Affected
365 kits US
Distribution
US Nationwide distribution.
Location
Portage, MI

Frequently Asked Questions

What product was recalled?
EliA dsDNA Well - Product Usage: intended for the In-Vitro quantitative measurement of IgG antibodies directed to dsDNA in human serum and plasma as an aid in the clinical diagnosis of systemic lupus erythematosus (SLE). Material Number: 14-5500-01. Recalled by Phadia US Inc. Units affected: 365 kits US.
Why was this product recalled?
Decreased values for EliA ANA Positive Control when using the EliA dsDNA Well lot BFA37/0142 may potentially cause false positive results (increase in patient test results).
Which agency issued this recall?
This recall was issued by the FDA Devices on February 17, 2021. Severity: Moderate. Recall number: Z-1107-2021.